Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

Market is overlooking Gerald's "Ace In the Hole":

F.D.A. granting the O.D.D. for MANF for Retinitis Pigmentosa.

I expect it will happen and AMBS will ink a development deal that will yield a substantial up-front cash payment and put "MANF" on the bio-tech map.

Stay tuned for news.

Twitter: @AmarantusBio .... 10,200 followers.

p.s. If someone wants to sell shares for under eight cent there will be buyers. Possibly Gerald will be one of them as under eight cents is better than .086.